Your browser doesn't support javascript.
loading
Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials.
Cappelletti, Christy; Maes, Andrea; Rossman, Kimberly; Gillen, Michael; LaForce, Craig; Kerwin, Edward M; Reisner, Colin.
Afiliação
  • Cappelletti C; BioPharmaceuticals R&D, AstraZeneca, 4322 Emperor Blvd, Suite 250, Durham, NC, 27703, USA. christy.cappelletti1@astrazeneca.com.
  • Maes A; BioPharmaceuticals R&D, AstraZeneca, Wilmington, DE, USA.
  • Rossman K; BioPharmaceuticals R&D, AstraZeneca, Wilmington, DE, USA.
  • Gillen M; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • LaForce C; North Carolina Clinical Research, Raleigh, NC, USA.
  • Kerwin EM; Clinical Trials Department, Altitude Clinical Consulting and Clinical Research Institute, Medford, OR, USA.
  • Reisner C; BioPharmaceuticals R&D, AstraZeneca, Wilmington, DE, USA.
Clin Drug Investig ; 41(6): 579-590, 2021 Jun.
Article em En | MEDLINE | ID: mdl-34089147
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Broncodilatadores / Albuterol Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Broncodilatadores / Albuterol Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article